Related Experiment Videos
Is rocuronium an exception to the relation between onset and offset? A comparison with pipecuronium
A J England1, K Panikkar, I Redai
1John Hammond Department of Anaesthesia, East Surrey Hospital, Redhill, UK.
European Journal of Anaesthesiology
|July 1, 1996
Summary
Rocuronium recovery is significantly slower than its onset, unlike other neuromuscular blocking agents. This suggests rocuronium may have a unique mechanism of action affecting blockade and recovery.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Non-depolarizing neuromuscular blocking agents typically exhibit a consistent relationship between onset and recovery rates.
- Recovery is generally about ten times slower than the onset of blockade for these agents.
- This suggests a shared mechanism of action among non-depolarizing agents.
Purpose of the Study:
- To investigate the onset and recovery characteristics of rocuronium, a steroidal non-depolarizing agent.
- To compare rocuronium's blockade dynamics with pipecuronium, another non-depolarizing agent.
- To test the hypothesis that non-depolarizing agents share a common mechanism of action.
Main Methods:
- Utilized the isolated human forearm model to assess neuromuscular blockade.
- Calculated the rates of onset and recovery for rocuronium.
- Compared these rates with those of pipecuronium.
Main Results:
- Rocuronium demonstrated a mean recovery time/onset time ratio of 31.3.
- Pipecuronium exhibited a mean recovery time/onset time ratio of 11.6.
- The ratio for rocuronium was significantly greater than for pipecuronium (P < 0.01).
Conclusions:
- Rocuronium's recovery rate is disproportionately slower relative to its onset rate compared to pipecuronium.
- Rocuronium deviates from the established general relation between onset and offset seen with other non-depolarizing agents.
- This suggests rocuronium may possess a distinct mechanism of action influencing its neuromuscular blockade and recovery profile.